{"id":121633,"date":"2026-03-24T05:00:28","date_gmt":"2026-03-24T12:00:28","guid":{"rendered":"https:\/\/ixcellsbiotech.com\/?p=121633"},"modified":"2026-03-23T13:42:11","modified_gmt":"2026-03-23T20:42:11","slug":"organoid-chemotherapy-toxicity-human-ipsc-collaboration","status":"publish","type":"post","link":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/","title":{"rendered":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids<\/b>\n<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

San Diego, CA, 24 March 2026: iXCells Biotechnologies (\u201ciXCells\u201d), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences<\/a> (\u201cRosebud\u201d), Kantify<\/a>, and Incite<\/a> to evaluate off-target chemotherapeutic toxicities in patient-specific organoids<\/a>. Building on iXCells\u2019 recent partnership with Rosebud1<\/sup> and funded by Incite, the project will initially focus on predicting toxicity in heart, liver, and kidney tissue models, to develop personalized, multi-organ toxicity profiles for novel chemotherapies.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

Development of patient-specific human organoids models for heart, liver, and kidney tissues<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

During the collaboration, iXCells will reprogram peripheral blood mononuclear cells (PBMCs) isolated from the blood of a patient with liposarcoma, a rare, malignant cancer that originates in fatty tissues, into human induced pluripotent stem cells (hiPSCs). Rosebud, an innovator in organoid development and complex 3D biology, will then differentiate these hiPSCs into heart, liver, and kidney organoids using its industrialized organoid platform and perform the drug toxicity studies on investigational chemotherapeutic compounds supplied by Kantify, a Belgian company using a novel AI discovery engine called Sapian to discover novel targets and drugs for underserved diseases.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Toxicity will be quantified through longitudinal imaging and machine learning driven analysis, cardiac activity measurements, live\/dead viability assays, tissue-specific immunocytochemistry, and multiparametric readouts of structural and functional organ injury.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Unforeseen off-target toxicity in critical organs remains one of the most significant risks for cancer patients receiving chemotherapy, with injury to the heart, liver, or kidneys being a leading cause of clinical trial failures.2<\/sup> By assessing chemotherapeutic toxicities directly in organoids developed from a patient\u2019s own cells, the collaboration will generate personalized toxicity profiles to guide therapeutic decision making.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Steve Smith, Chief Executive Officer of iXCells Biotechnologies, commented: <\/strong>\u201cWe are excited to be collaborating with Rosebud, Kantify, and Incite on this joint initiative to demonstrate how hiPSC technologies and organoid systems can transform precision toxicology. <\/em>By starting from a patient\u2019s own cells, we gain unprecedented insight into off-target toxicity, one of the biggest challenges in developing safer and more effective cancer therapeutics.\u201d<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Kitch Wilson, MD, PhD, CEO and Co-Founder of Rosebud Biosciences added: <\/strong>\u201cThis project is addressing one of the most urgent questions in oncology, determining whether a patient\u2019s vital organs can tolerate lifesaving therapies. By combining our scalable organoid technology with iXCells\u2019 expertise in cellular reprogramming and Kantify\u2019s AI drug discovery platform, we are creating a patient specific testing system for novel chemotherapy drugs that reflects exactly the type of new approach methodologies the FDA is encouraging.\u201d<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Visit iXCells\u2019 human cell-based solutions and custom iPSC services page<\/a> for more information.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t

References<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. https:\/\/ixcellsbiotech.com\/ixcells-biotechnologies-and-rosebud-biosciences-partner-to-advance-organoid-based-models-for-rare-diseases\/<\/a><\/li>
  2. https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8777973\/<\/a><\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t

    About iXCells Biotechnologies<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    iXCells Biotechnologies (\u201ciXCells\u201d) is a leading San Diego, California-based cell technology company focused on generating a wide variety of predictive human disease models. In addition, iXCells is pursuing custom and patient-specific services leveraging its expertise in the preparation, handling, engineering and differentiation of induced pluripotent stem cells (iPSCs) and in the isolation of primary cells along with associated services for descriptive and functional cell characterization, compound screening and toxicology testing.<\/p>

    The company\u2019s mission is to supply a diverse range of human disease models, derived from ethically sourced patient and healthy donor tissues, to support academic, pharmaceutical, and clinical researchers globally. By providing predictive human cell models, we aim to deepen the understanding of the molecular mechanisms underlying disease onset and progression as much as slow-down or reversion of disease, and accelerate the discovery and development of new medicines and innovative therapies to further advance precision medicine.<\/p>

    Media Contacts<\/strong><\/p>

    Christy Holt
    VP of Marketing and Sales
    christy.holt@ixcellsbiotech.com
    iXCellsBiotech.com<\/a><\/p>

    To request more information visit
    iXCells on Linkedin,<\/a>
    and iXCells on YouTube.<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t

    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t\t
    \n\t\t\t
    \n\t\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t
    COMPANY NEWS<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\n\t\t\t\t\t\t
    \n\t\t\t\t\n\t\t\t\t<\/i>\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t
    \n\n\t\t\t\t\t\t\t\t\t

    \n\t\t\t\t\t\t\n\t\t\t\t\t\t\tJoint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h4>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t

    \n\t\t\t\t\t\tiXCells joins global collaboration to assess chemotherapy toxicity using patient-specific human organoids and iPSC technology, advancing precision toxicology.\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tCONTACT US TODAY<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    iXCells Biotechnologies develops a diverse range of off-the-shelf and custom iPSC-derived cell models\u2014sourced from both healthy and patient donors\u2014with the goal of enabling \u201cclinical-trials-in-a-plate.\u201d<\/p>\n","protected":false},"author":234903478,"featured_media":121628,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"elementor_header_footer","format":"standard","meta":{"_acf_changed":false,"content-type":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_wpcom_ai_launchpad_first_post":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":true},"categories":[1889],"tags":[],"news_type":[2168],"news_areas":[],"class_list":["post-121633","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news","news_type-company-news"],"acf":[],"yoast_head":"\niXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids<\/title>\n<meta name=\"description\" content=\"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids\" \/>\n<meta property=\"og:description\" content=\"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/\" \/>\n<meta property=\"og:site_name\" content=\"iXCells\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-24T12:00:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg?fit=1200%2C520&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"520\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"kfaulkner9a16998ec4\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@iXCells\" \/>\n<meta name=\"twitter:site\" content=\"@iXCells\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kfaulkner9a16998ec4\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/\"},\"author\":{\"name\":\"kfaulkner9a16998ec4\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/person\\\/2a6cf137175bc92f940b947525db5651\"},\"headline\":\"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids\",\"datePublished\":\"2026-03-24T12:00:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/\"},\"wordCount\":684,\"publisher\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg\",\"articleSection\":[\"Company News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/\",\"name\":\"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg\",\"datePublished\":\"2026-03-24T12:00:28+00:00\",\"description\":\"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg\",\"contentUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg\",\"width\":1200,\"height\":520,\"caption\":\"Human Organoids Header Image V02\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#website\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\",\"name\":\"iXCells Biotechnologies\",\"description\":\"Human Relevant Cell Model Expert | iPSC | Primary Cells\",\"publisher\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ixcellsbiotech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#organization\",\"name\":\"iXCells Biotechnologies USA, Inc.\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Logo.png\",\"contentUrl\":\"https:\\\/\\\/ixcellsbiotech.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Logo.png\",\"width\":256,\"height\":64,\"caption\":\"iXCells Biotechnologies USA, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/iXCells\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ixcells-biotechnologies\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ixcellsbiotech.com\\\/#\\\/schema\\\/person\\\/2a6cf137175bc92f940b947525db5651\",\"name\":\"kfaulkner9a16998ec4\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g\",\"caption\":\"kfaulkner9a16998ec4\"},\"url\":\"https:\\\/\\\/ixcellsbiotech.com\\\/author\\\/kfaulkner9a16998ec4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids","description":"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/","og_locale":"en_US","og_type":"article","og_title":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids","og_description":"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients","og_url":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/","og_site_name":"iXCells","article_published_time":"2026-03-24T12:00:28+00:00","og_image":[{"width":1200,"height":520,"url":"https:\/\/i0.wp.com\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg?fit=1200%2C520&ssl=1","type":"image\/jpeg"}],"author":"kfaulkner9a16998ec4","twitter_card":"summary_large_image","twitter_creator":"@iXCells","twitter_site":"@iXCells","twitter_misc":{"Written by":"kfaulkner9a16998ec4","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#article","isPartOf":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/"},"author":{"name":"kfaulkner9a16998ec4","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/person\/2a6cf137175bc92f940b947525db5651"},"headline":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids","datePublished":"2026-03-24T12:00:28+00:00","mainEntityOfPage":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/"},"wordCount":684,"publisher":{"@id":"https:\/\/ixcellsbiotech.com\/#organization"},"image":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#primaryimage"},"thumbnailUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg","articleSection":["Company News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/","url":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/","name":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids","isPartOf":{"@id":"https:\/\/ixcellsbiotech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#primaryimage"},"image":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#primaryimage"},"thumbnailUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg","datePublished":"2026-03-24T12:00:28+00:00","description":"Joint initiative with Rosebud Biosciences, Kantify will identify and quantify off-target toxicities in chemotherapy patients","breadcrumb":{"@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#primaryimage","url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg","contentUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg","width":1200,"height":520,"caption":"Human Organoids Header Image V02"},{"@type":"BreadcrumbList","@id":"https:\/\/ixcellsbiotech.com\/organoid-chemotherapy-toxicity-human-ipsc-collaboration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ixcellsbiotech.com\/"},{"@type":"ListItem","position":2,"name":"iXCells Biotechnologies Joins International Collaboration to Evaluate Chemotherapeutic Toxicity in Human Organoids"}]},{"@type":"WebSite","@id":"https:\/\/ixcellsbiotech.com\/#website","url":"https:\/\/ixcellsbiotech.com\/","name":"iXCells Biotechnologies","description":"Human Relevant Cell Model Expert | iPSC | Primary Cells","publisher":{"@id":"https:\/\/ixcellsbiotech.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ixcellsbiotech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ixcellsbiotech.com\/#organization","name":"iXCells Biotechnologies USA, Inc.","url":"https:\/\/ixcellsbiotech.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/logo\/image\/","url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2023\/06\/Logo.png","contentUrl":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2023\/06\/Logo.png","width":256,"height":64,"caption":"iXCells Biotechnologies USA, Inc."},"image":{"@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/iXCells","https:\/\/www.linkedin.com\/company\/ixcells-biotechnologies"]},{"@type":"Person","@id":"https:\/\/ixcellsbiotech.com\/#\/schema\/person\/2a6cf137175bc92f940b947525db5651","name":"kfaulkner9a16998ec4","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89a7d563dce165323e2b05f8231899e8226ded71ae78e1309cc6d4e045087a52?s=96&d=identicon&r=g","caption":"kfaulkner9a16998ec4"},"url":"https:\/\/ixcellsbiotech.com\/author\/kfaulkner9a16998ec4\/"}]}},"jetpack_publicize_connections":[],"jetpack_shortlink":"https:\/\/wp.me\/peN4gs-vDP","jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/ixcellsbiotech.com\/wp-content\/uploads\/2026\/03\/Human-Organoids-Header-Image-dV02-1200px-520px.jpg","_links":{"self":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/121633","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/users\/234903478"}],"replies":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/comments?post=121633"}],"version-history":[{"count":15,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/121633\/revisions"}],"predecessor-version":[{"id":121743,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/posts\/121633\/revisions\/121743"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/media\/121628"}],"wp:attachment":[{"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/media?parent=121633"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/categories?post=121633"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/tags?post=121633"},{"taxonomy":"news_type","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/news_type?post=121633"},{"taxonomy":"news_areas","embeddable":true,"href":"https:\/\/ixcellsbiotech.com\/wp-json\/wp\/v2\/news_areas?post=121633"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}